These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 33458659

  • 1. Retrospective Analysis of the Factors Affecting Growth Parameters in Turkish Children With Systemic Lupus Erythematosus.
    Balci S, KiŞla Ekİncİ RM, Melek E, Karabay Bayazit A, DoĞruel D, Ufuk AltintaŞ D, Yilmaz M.
    Arch Rheumatol; 2020 Sep; 35(3):357-365. PubMed ID: 33458659
    [Abstract] [Full Text] [Related]

  • 2. Juvenile systemic lupus erythematosus: a single-center experience from southern Turkey.
    Balci S, Ekinci RMK, Bayazit AK, Melek E, Dogruel D, Altintas DU, Yilmaz M.
    Clin Rheumatol; 2019 May; 38(5):1459-1468. PubMed ID: 30648229
    [Abstract] [Full Text] [Related]

  • 3. Correlation between the Modified Systemic Lupus Erythematosus Disease Activity Index 2000 and the European Consensus Lupus Activity Measurement in juvenile systemic lupus erythematosus.
    Sato JO, Corrente JE, Saad-Magalhães C.
    Lupus; 2016 Nov; 25(13):1479-1484. PubMed ID: 27230556
    [Abstract] [Full Text] [Related]

  • 4. Bone mineral density in children and adolescents with systemic lupus erythematosus, juvenile dermatomyositis, and systemic vasculitis: relationship to disease duration, cumulative corticosteroid dose, calcium intake, and exercise.
    Alsufyani KA, Ortiz-Alvarez O, Cabral DA, Tucker LB, Petty RE, Nadel H, Malleson PN.
    J Rheumatol; 2005 Apr; 32(4):729-33. PubMed ID: 15801032
    [Abstract] [Full Text] [Related]

  • 5. Cumulative pulse methylprednisolone and its relation to disease activity, damage and mortality in systemic lupus erythematosus patients: A post hoc analysis of COMOSLE-EGYPT study.
    Sobhy N, Ezzat Y, Gamal SM, Ghoniem SA, Nasr SS, Badran S, Soliman A, Fouad NA.
    Clin Rheumatol; 2024 Mar; 43(3):985-992. PubMed ID: 38198114
    [Abstract] [Full Text] [Related]

  • 6. Disease characteristics in patients with juvenile- and adult-onset systemic lupus erythematosus: A multi-center comparative study.
    Gamal SM, Fouad N, Yosry N, Badr W, Sobhy N.
    Arch Rheumatol; 2022 Jun; 37(2):280-287. PubMed ID: 36017206
    [Abstract] [Full Text] [Related]

  • 7. Rituximab Biosimilar BCD020 Shows Superior Efficacy above Conventional Non-Biologics Treatment in Pediatric Lupus Nephritis: The Data of Retrospective Cohort Study.
    Kostik M, Kalashnikova E, Rinat R, Isupova E, Gaidar E, Soloviev AA, Masalova V, Snegireva L, Kornishina T, Abramova N, Suspitsin E, Sorokina L, Kaneva M, Dubko MF, Lubimova N, Kuchuinskaya E, Kalashnikova O, Chasnyk V.
    Biomedicines; 2023 May 22; 11(5):. PubMed ID: 37239173
    [Abstract] [Full Text] [Related]

  • 8. Urinary interleukin 22 binding protein as a marker of lupus nephritis in Egyptian children with juvenile systemic lupus erythematosus.
    Badr AMM, Farag Y, Abdelshafy M, Riad NM.
    Clin Rheumatol; 2018 Feb 22; 37(2):451-458. PubMed ID: 28887660
    [Abstract] [Full Text] [Related]

  • 9. Severe disease presentation and poor outcomes among pediatric systemic lupus erythematosus patients in South Africa.
    Lewandowski LB, Schanberg LE, Thielman N, Phuti A, Kalla AA, Okpechi I, Nourse P, Gajjar P, Faller G, Ambaram P, Reuter H, Spittal G, Scott C.
    Lupus; 2017 Feb 22; 26(2):186-194. PubMed ID: 27488473
    [Abstract] [Full Text] [Related]

  • 10. A longitudinal PRINTO study on growth and puberty in juvenile systemic lupus erythematosus.
    Rygg M, Pistorio A, Ravelli A, Maghnie M, Di Iorgi N, Bader-Meunier B, Da Silva C, Roldan-Molina R, Barash J, Dracou C, Laloum SG, Jarosova K, Deslandre CJ, Koné-Paut I, Garofalo F, Press J, Sengler C, Tauber T, Martini A, Ruperto N, Paediatric Rheumatology International Trials Organisation (PRINTO).
    Ann Rheum Dis; 2012 Apr 22; 71(4):511-7. PubMed ID: 21998114
    [Abstract] [Full Text] [Related]

  • 11. Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups.
    Massias JS, Smith EMD, Al-Abadi E, Armon K, Bailey K, Ciurtin C, Davidson J, Gardner-Medwin J, Haslam K, Hawley DP, Leahy A, Leone V, McErlane F, Mewar D, Modgil G, Moots R, Pilkington C, Ramanan AV, Rangaraj S, Riley P, Sridhar A, Wilkinson N, Beresford MW, Hedrich CM.
    Lupus; 2020 Apr 22; 29(5):474-481. PubMed ID: 32233733
    [Abstract] [Full Text] [Related]

  • 12. Predisposing Factors of Tuberculosis Infection in Systemic Lupus Erythematosus Patients: A Single-Center Case-Control Study.
    Damara I, Ariane A, Winston K.
    Cureus; 2022 Jun 22; 14(6):e26410. PubMed ID: 35915698
    [Abstract] [Full Text] [Related]

  • 13. Synergistic effect of cumulative corticosteroid dose and immunosuppressants on avascular necrosis in patients with systemic lupus erythematosus.
    Kwon HH, Bang SY, Won S, Park Y, Yi JH, Joo YB, Lee HS, Bae SC.
    Lupus; 2018 Sep 22; 27(10):1644-1651. PubMed ID: 29950160
    [Abstract] [Full Text] [Related]

  • 14. Childhood Systemic Lupus Erythematosus: Presentation, management and long-term outcomes in an Australian cohort.
    Cann MP, Sage AM, McKinnon E, Lee SJ, Tunbridge D, Larkins NG, Murray KJ.
    Lupus; 2022 Feb 22; 31(2):246-255. PubMed ID: 35037500
    [Abstract] [Full Text] [Related]

  • 15. Long-term growth and final adult height outcome in childhood-onset systemic lupus erythematosus.
    Ponin L, Poomthavorn P, Pirojsakul K, Lerkvaleekul B, Soponkanaporn S, Chitrapazt N, Vilaiyuk S.
    Pediatr Rheumatol Online J; 2022 Jan 24; 20(1):4. PubMed ID: 35073942
    [Abstract] [Full Text] [Related]

  • 16. A Comparison of the Correlation of Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) and Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) with Health-Related Quality of Life.
    Lai NS, Lu MC, Chang HH, Lo HC, Hsu CW, Huang KY, Tung CH, Hsu BB, Wu CH, Koo M.
    J Clin Med; 2021 May 15; 10(10):. PubMed ID: 34063379
    [Abstract] [Full Text] [Related]

  • 17. Association of systemic lupus erythematosus disease activity index score with clinical and laboratory parameters in pediatric onset systemic lupus erythematosus.
    Shamim R, Farman S, Batool S, Khan SEA, Raja MKH.
    Pak J Med Sci; 2020 May 15; 36(3):467-472. PubMed ID: 32292454
    [Abstract] [Full Text] [Related]

  • 18. SLICC/ACR Damage Index in Afro-Caribbean patients with systemic lupus erythematosus: changes in and relationship to disease activity, corticosteroid therapy, and prognosis.
    Nossent JC.
    J Rheumatol; 1998 Apr 15; 25(4):654-9. PubMed ID: 9558165
    [Abstract] [Full Text] [Related]

  • 19. Treatment pathways in an inception lupus cohort over the first three years.
    Hanly JG, Sayani A, Doucette S, Iczkovitz S, Terres JAR.
    Lupus; 2017 Feb 15; 26(2):119-124. PubMed ID: 27365369
    [Abstract] [Full Text] [Related]

  • 20. Juvenile systemic lupus erythematosus in Turkey: demographic, clinical and laboratory features with disease activity and outcome.
    Sahin S, Adrovic A, Barut K, Canpolat N, Ozluk Y, Kilicaslan I, Caliskan S, Sever L, Kasapcopur O.
    Lupus; 2018 Mar 15; 27(3):514-519. PubMed ID: 29233038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.